EUVIMEDEUVIMED entdecken
Crossref

Semiparametric pseudo‐score and pseudo‐likelihood for evaluating correlate of protection in vaccine trials

Wanying Ma, Mengya Liu, Jian Zhu iD, Qing Li iD, Elaine Hoffman, Jianchang Lin iD

Statistics in Medicine · 2023

DOI: 10.1002/sim.9807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2023. Verfasst von Wanying Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Novartis Pharmaceuticals, East Hanover, New Jersey, USA. Hauptthemen laut MEDLINE: Vaccines. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vaccine clinical trials, vaccine efficacy endpoint analysis is usually associated with in high cost or extended study duration, due to the generally low infection rate. Correlate of protection (CoP), which refers to surrogate endpoint, usually immunological response, that can reliably predict the treatment effect, provides a more efficient and less costly approach to evaluate the vaccine. To handle the challenge of the missingness in the unobserved surrogate immune biomarker, the pseudo‐score (PS) method, semiparametric method and pseudo‐likelihood (PL) method demonstrated their advantages on different aspects. In this article, we propose new methodologies to combine the advantages of PS and PL with semiparametric methods respectively, to achieve higher estimate efficiency, allow continuous baseline predictor variable, and handle multiple surrogate markers. The advantage of our methodologies are demonstrated by a simulation study in different settings and applied to a case study, which eventually can improve the chance of a successful trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VaccinesHumansBiomarkersComputer SimulationLikelihood FunctionsClinical Trials as Topic

Stichwörter der Autor:innen

correlate of protectionsemiparametric modelvaccine development

Substanzen

BiomarkersVaccines

Autor:innen und Institutionen

  • Novartis Pharmaceuticals, East Hanover, New Jersey, USA.
  • Takeda Pharmaceuticals, Cambridge, Massachusetts, USA.
  • Servier Pharmaceuticals, Boston, Massachusetts, USA.
  • MorphoSys US, Inc., Boston, Massachusetts, USA.

ORCID-Profile: Jian Zhu, Qing Li, Jianchang Lin

Zitieren

APA

Ma, W., Liu, M., Zhu, J., Li, Q., Hoffman, E., & Lin, J. (2023). Semiparametric pseudo‐score and pseudo‐likelihood for evaluating correlate of protection in vaccine trials. Statistics in Medicine. https://doi.org/10.1002/sim.9807

Vancouver

Ma W, Liu M, Zhu J, Li Q, Hoffman E, Lin J. Semiparametric pseudo‐score and pseudo‐likelihood for evaluating correlate of protection in vaccine trials. Statistics in Medicine. 2023. doi:10.1002/sim.9807

BibTeX
@article{Ma2023,
  author = {Ma, Wanying and Liu, Mengya and Zhu, Jian and Li, Qing and Hoffman, Elaine and Lin, Jianchang},
  title = {Semiparametric pseudo‐score and pseudo‐likelihood for evaluating correlate of protection in vaccine trials},
  journal = {Statistics in Medicine},
  year = {2023},
  doi = {10.1002/sim.9807}
}
Kostenlos starten →